EPCLUSA Support Line Questions about Hep C treatment or cost? Call 1-844-4-EPCLUSA (1-844-437-2587) to speak with an EPCLUSA Educator 7 days a week, even if you don't have a prescription.
Full Answer
What is the Epclusa Patient Assistance Program?
Patient Assistance Programs for Epclusa Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program. Provider: Support Path Patient Assistance Program
How much does it cost to buy Epclusa?
Commercial patients may pay as little as $15 for a full course of treatment of EPCLUSA or its Authorized Generic. 2 Help patients register for a co-pay coupon. Commercial patients may pay as little as $15 for a full course of EPCLUSA or its Authorized Generic Commercial patients may pay as little as $5 per co-pay for their medicine.
What is the Epclusa co-pay coupon program?
The EPCLUSA Co-pay Coupon Program will cover the out-of-pocket costs for EPCLUSA prescriptions up to a maximum of 25% of the catalog price of a 12-week regimen of EPCLUSA. 99% of Medicaid patients taking EPCLUSA or its Authorized Generic pay $5 or less per co-pay. 3,a
Are all calls with Epclusa educators confidential?
All calls with EPCLUSA Educators are completely confidential and private. Nurse support does not take the place of talking with your Hep C Specialist. If you’ve been diagnosed with Hep C, you can get the personalized support you deserve.
How much does Epclusa cost in Canada?
Drugs used to treat hepatitis, including Sovaldi, pictured above, and the newly approved Epclusa have been shown to be remarkably effective. But they come at a high cost. Epclusa will cost about $75,000 for a 12-week course.
How much is a 28 day supply of Epclusa?
The cost for Epclusa oral pellet (150 mg-37.5 mg) is around $26,250 for a supply of 28 pellet, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Does insurance pay for Epclusa?
Epclusa is usually covered by most commercial health insurance plans, Medicare, and some Medicaid plans. Coverage may require prior authorization. The out-of-pocket expense, however, will depend on the insurance plan's formulary, deductibles, and coinsurance.
How much does Epclusa cost per pill?
Your monthly Epclusa cost savings if eligibleStrengthAvg. monthly price at a US pharmacyNiceRx monthly price400/100mg 28 tablets$25,600.00$49.00
What is the success rate of Epclusa?
Effectiveness: The cure rates are from 97% to 100% in those without cirrhosis or with compensated cirrhosis. Side effects: Most people don't experience significant side effects – but if they do the most common adverse reactions observed with treatment with Epclusa for 12 weeks are headache and fatigue.
How much does generic Epclusa cost?
(Sofosbuvir-Velpatasvir) Epclusa is an antiviral prescription medication used to treat hepatitis C, which is a viral infection of the liver. The generic version of this drug is sofosbuvir-velpatasvir. The average retail price of Epclusa is about $38,104.54 for 1, 28 Tablets Tablet.
Is there a generic for Epclusa?
In January 2019, Asegua Therapeutics, a subsidiary of Gilead Sciences, launched authorized generic versions of Gilead's Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) tablets.
What happens if you drink alcohol while taking Epclusa?
Alcohol may increase the risk of side effects with Epclusa, such as nausea, diarrhea, fatigue, and headache. Alcohol itself can also cause liver inflammation and liver scarring (cirrhosis). Drinking alcohol while taking Epclusa may increase the risk of cirrhosis and liver failure.
Does Epclusa cure hep C?
by Drugs.com Yes, Epclusa (sofosbuvir and velpatasvir) can cure hepatitis C virus (HCV) in many patients and has a 98% overall cure rate in all 6 of the main types of hepatitis C. "Cure” means the Hep C virus is not detected in the blood when measured three months after treatment is completed.
Does Epclusa cause weight gain?
No, Epclusa doesn't affect your body weight. But weight loss can be a sign of infections, including hepatitis C. And keep in mind that Epclusa is used to treat hepatitis C. You may also lose weight if you have nausea while you're taking Epclusa.
Does Epclusa cause hair loss?
Hair loss. Hair loss didn't occur in clinical trials of Epclusa. Some people have reported losing hair during Epclusa treatment.
Can you drink coffee with Epclusa?
HEADACHE. Drink water. Limit coffee, tea, and soda with caffeine.
Is there a generic for Epclusa?
In January 2019, Asegua Therapeutics, a subsidiary of Gilead Sciences, launched authorized generic versions of Gilead's Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) tablets.
What is the average cost of ribavirin?
Ribavirin is an antiviral drug that is part of a group of medications called nucleoside analogues. Continue to our FAQs section for more information about Ribavirin. Ribavirin costs $1,364.09 at full price. A SingleCare Ribavirin coupon reduces that price to $87.56.
What is the generic name for Epclusa?
Generic Name: sofosbuvir-velpatasvir This medication is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).
How much does Epclusa cost in the UK?
Epclusa costs nearly £39,000 for a 12-week course and £40,000 when taken in combination with ribavirin.
What is EPCLUSA?
EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated).
What should I tell my healthcare provider before taking EPCLUSA?
Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection, liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk.
What are the side effects of epclua?
The most common side effects of EPCLUSA include headache and tiredness. The most common side effects of EPCLUSA when used with ribavirin in adults with decompensated cirrhosis are tiredness, low red blood cells, nausea, headache, trouble sleeping, and diarrhea.
Does epclua cause headaches?
The most common side effects of EPCLUSA in adults include headache and tiredness. The most common side effects of EPCLUSA when used with ribavirin in adults with decompensated cirrhosis are tiredness, low red blood cells, nausea, headache, trouble sleeping, and diarrhea.
How much does EPCLUSA cost?
Help patients register for a co-pay coupon. Commercial patients may pay as little as $15 for a full course of EPCLUSA or its Authorized Generic
What is the dosage of EpclUSA?
EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg, 200 mg/50 mg tablets; 200 mg/50 mg, 150 mg/37.5 mg oral pellets) is indicated for the treatment of patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis.
What are the adverse reactions to EPCLUSA?
The most common adverse reactions (≥10%, all grades) with EPCLUSA were headache and fatigue; and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.
Is EPCLUSA a generic?
With EPCLUSA and its Authorized Generic, you have access for the majority of your insured HCV patients.
How much does a commercial patient pay for a copay?
Commercial patients may pay as little as $5 per co-pay for their medicine. Patients are not eligible if they are enrolled in a government healthcare prescription drug program such as Medicare Part D or Medicaid (including patients who are in the Medicare coverage gap known as the “donut hole”).
Is the Real-World Integrated Analysis presented in the EPCLUSA?
The Real-World Integrated Analysis is not presented in the EPCLUSA full Prescribing Information.
Where were patients treated?
Patients were treated in different clinical settings, including university hospitals, academic centers, community centers, outpatient clinics and private practices. Treatment and patient monitoring were based on local clinical practice and standard of care, at the discretion of the treating physician.
What is Epclusa used for?
Epclusa (sofosbuvir/velpatasvir) is a member of the antiviral combinations drug class and is commonly used for Hepatitis C.
Is Epclusa valid with insurance?
Prices are for cash paying customers only and are not valid with insurance plans. A generic version of Epclusa is available, see sofosbuvir/velpatasvir prices.
What is the dosage of EpclUSA?
EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg, 200 mg/50 mg tablets; 200 mg/50 mg, 150 mg/37.5 mg oral pellets) is indicated for the treatment of patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis.
What are the adverse reactions to EPCLUSA?
The most common adverse reactions (≥10%, all grades) with EPCLUSA were headache and fatigue; and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.
Can hepatitis B be reactivated with EPCLUSA?
BOXED WARNING: RISK OF HEPATITIS B VIRUS REACTIVATION IN HCV/HBV COINFECTED PATIENTS Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with EPCLUSA. HBV reactivation has been reported in HCV/HBV coinfected patients who were undergoing or had completed treatment with HCV direct-acting antivirals (DAAs) and were not receiving HBV antiviral therapy. Some cases have resulted in fulminant hepatitis, hepatic failure, and death. Cases have been reported in patients who are HBsAg positive, in patients with serologic evidence of resolved HBV, and also in patients receiving certain immunosuppressant or chemotherapeutic agents; the risk of HBV reactivation associated with treatment with HCV DAAs may be increased in patients taking these other agents. Monitor HCV/HBV coinfected patients for hepatitis flare or HBV reactivation during HCV treatment and post-treatment follow-up. Initiate appropriate patient management for HBV infection as clinically indicated.
Who was excluded from the ASTRAL pivotal trial?
Patients who were active injection drug users (use within 12 months), or those with a positive urine drug test at screening, were excluded from the ASTRAL pivotal trials.
Can you take epclusa with phenobarbital?
Coadministration of EPCLUSA is not recommended with proton-pump inhibitors, phenobarbital, phenytoin, rifabutin, rifapentine, efavirenz, and tipranavir/ritonavir due to decreased concentrations of sofosbuvir and/or velpatasvir.
Support Path is here to help
Help get your patients started today through the resources below, or call Support Path to connect live with a Program Navigator.
Direct Patients to Submit a Support Path Enrollment Form
Support Path can help patients understand insurance coverage and financial support options to get started. Use the Support Path Enrollment Form to select from the following support options:
Cost should not be a barrier to treatment. Register patients for a co-pay coupon
A co-pay coupon may help eligible patients reduce out-of-pocket costs of Gilead or Asegua treatment.
iAssist
Submit prescriptions, PA forms, and the Support Path Enrollment Form electronically through iAssist. Forms are submitted directly to the payer and Support Path. Register or log in below.
